Related Experiment Video
Updated: Aug 23, 2025
Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer
Published on: September 8, 2023
Recent Advances in DNA Vaccines against Lung Cancer: A Mini Review
Ting Huang1, Li Liu2, Zheng Lv1
1Antibiotics Research and Re-Evaluation Key Laboratory of Sichuan Province, School of Pharmacy, Chengdu University, Chengdu 610052, China.
Abstract:
Lung cancer is regarded as the major causes of patient death around the world. Although the novel tumor immunotherapy has made great progress in the past decades, such as utilizing immune checkpoint inhibitors or oncolytic viruses, the overall 5-year survival of patients with lung cancers is still low. Thus, development of effective vaccines to treat lung cancer is urgently required. In this regard, DNA vaccines are now considered as a promising immunotherapy strategy to activate the host immune system against lung cancer. DNA vaccines are able to induce both effective humoral and cellular immune responses, and they possess several potential advantages such as greater stability, higher safety, and being easier to manufacture compared to conventional vaccination. In the present review, we provide a global overview of the mechanism of cancer DNA vaccines and summarize the innovative neoantigens, delivery platforms, and adjuvants in lung cancer that have been investigated or approved. Importantly, we highlight the recent advance of clinical studies in the field of lung cancer DNA vaccine, focusing on their safety and efficacy, which might accelerate the personalized design of DNA vaccine against lung cancer.
Insights
DNA vaccines offer a promising immunotherapy strategy for lung cancer, activating the immune system for better treatment. This review highlights advancements in DNA vaccine technology, including neoantigens and delivery platforms, for improved lung cancer survival.
Area of Science:
- Oncology
- Immunology
- Vaccinology
Background:
- Lung cancer remains a leading cause of cancer mortality worldwide.
- Current immunotherapies like checkpoint inhibitors show limitations, necessitating novel treatment strategies.
- Effective vaccines are crucial for improving lung cancer patient survival rates.
Purpose of the Study:
- To provide a comprehensive overview of DNA vaccines as an immunotherapy for lung cancer.
- To summarize recent innovations in lung cancer DNA vaccine development, including neoantigens, delivery systems, and adjuvants.
- To highlight clinical advancements, focusing on the safety and efficacy of lung cancer DNA vaccines.
Main Methods:
- Review of existing literature on DNA vaccines for lung cancer.
- Analysis of novel neoantigens, delivery platforms, and adjuvants.
- Examination of clinical trial data on lung cancer DNA vaccine safety and efficacy.
Main Results:
- DNA vaccines demonstrate potential for inducing robust humoral and cellular immune responses.
- Advantages include enhanced stability, safety, and ease of manufacturing compared to traditional vaccines.
- Recent clinical studies show promising safety and efficacy profiles for lung cancer DNA vaccines.
Conclusions:
- DNA vaccines represent a promising and adaptable immunotherapy approach for lung cancer.
- Further research and clinical trials are essential to optimize personalized DNA vaccine design for lung cancer.
- Advancements in neoantigen identification and delivery systems are key to maximizing therapeutic potential.
More Related Videos
10:18Author Spotlight: Magnetic Fluorescent Bead-Based Dual-Reporter Flow Analysis of PDL1-Vaxx Peptide Vaccine-Induced Antibody Blockade of the PD-1/PD-L1 Interaction
Published on: July 7, 2023
11:15Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors
Published on: September 20, 2016
Related Concept Videos
01:30Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
02:57Targeted Cancer Therapies
There are several types of targeted therapies against...